参考文献

[1]Moller JT,Cluitmans P,Rasmussen LS,et al.Long-term postoperative cognitive dysfunction in the elderly ISPOCDI study ISPOCD investigators.International Study of Post-Operative Cognitive Dysfunction.Lancet.,1998,351(9106):857-861.

[2]Zannis,Breslow.Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslationalmodification.Biochemistry,1981,20(4):1033-1041.

[3]Schmechel,Saunders,Strittmatter,et al.Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proc Natl Acad Sci USA,1993,90(20):9649-9653.

[4]Tardiff,Newman,Saunders,et al.Preliminary report of a genetic basis for cognitive decline after cardiac operations.Ann Thorac Surg,1997,715-720.

[5]Abildstrom,Christiansen,Siersma,et al.Apolipoprotein E genotype and cognitive dysfunction after noncardiac surgery.Anesthesiology,2004,101(4):855-861.

[6]McDonagh,Mathew,Barbara.Cognitive Function after Major Noncardiac Surgery,Apolipoprotein E4 Genotype,and Biomarkers of Brain Injury.Anesthesiology,2010,112:852-859.

[7]Bryson,Wyand,Wozny,et al.A prospective cohort study evaluating associations among delirium,postoperative cognitive dysfunction,and apolipoprotein E genotype following open aortic repair.Can J Anaesth,2011,58(3):246-255.

[8]Cai Y,Hu H,Liu P,et al.Association between the apolipoprotein E4 andpostoperative cognitive dysfunction in elderly patients undergoing intravenous anesthesia and inhalation anesthesia.Anesthesiology,2012,116:84-93.

[9]Karsten Bartels,Yi-Ju Li,Yen-Wei Li,et al.Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery:a retrospective cohort study.Can JAnesth/JCan Anesth,2015,62:618-626.

[10]Perez-Alcazar,Daborg,Stokowska,et al.Altered cognitive performance and synaptic function in the hippocampus ofmice lacking C3.Exp Neurol,2014,253:154-164.

[11]Rambausek,Wall Bake,Schumacher-Ach,et al.Genetic polymorphism of C3 and Bf in IgA nephropathy.Nephrol Dial Transplant,1987,2(4):208-211.

[12]Poznansky,Clissold,Lachmann,et al.The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha chain of the complement component,C3.J Immunol,1989,143(11):3860-3862.

[13]Welch TR1,Beischel L,Kleesattel A.Functional consequences of the genetic polymorphism of the third component of complement.JPediatr,1990,116(5):S92-97.

[14]Damman,Daha,Leuvenink et al.Association of complementC3 gene variantswith renal transplant outcome of deceased cardiac dead donor kidneys.Am JTransplant,2012,12(3):660-668.

[15]Gigante,Kotchetkov,Kellner et al.Polymorphisms in complemen t component 3(C3F)and complement factor H(Y402H)increase the risk of postoperative neuro cognitive dysfunct ion following carotid endarter ectomy.J Neurol Neurosurg Psychiatry,2011,82:247-253.

[16]Bart􀆑k,Walport Comparison of the Binding of C3Sand C3F to Complement Receptors Types 1,2,and 3′.The Journal of Immunology,1995,154:5367-5375.

[17]Mastellos,Complement emerges as a masterful regulator of CNS homeostasis,neural synaptic plasticity and cognitive function.Experimental Neurology 2014,261:469-474.

[18]Gretarsdottir,Thorleifsson,Reynisdotti.et al The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.Nat Genet,2003,35(2):131-138.

[19]Daniel;Ritesh Kaushal;Brett Kissela,et al Association of Phosphodiesterase 4D WithIschemic StrokeA Population-Based Case-Control Study.Stroke,2006,37:371-376.

[20]Liu X,Zhu R,Li L et al.Genetic polymorphism in PDE4D gene and risk of ischemic stroke in Chinese population:ameta-analysis.PLoSOne,2013,8(6):e66374.

[21]Yan Y,Luo XP,Zhang JL,et al.Association between phosphodiesterase 4D polymorphism SNP83 and ischemic stroke.Journal of the Neurological Sciences,2014,338(1-2):3-11.

[22]Schaefer,Braun,Amos-Kroohs,et al.A new model of Pde4d deficiency:genetic knock-down of PDE4D enzyme in rats produces an antidepressant phenotype without spatial cognitive effects.Genes Brain Behav,2012,11(5):614-622.

[23]Heyer,Mergeche,Ward,et al.Phosphodiesterase 4D Single-Nucleotide Polymorphism 83 and Cognitive Dysfunction in Carotid Endarterectomy Patients.Neurosurgery,2013,73(5):791-796.

[24]Li YF,Cheng YF,Huang Y,et al.Phosphodiesterase-4D knock-out and RNA interference-mediated knockdown enhancememory and increase hippocampal neurogenesis via increased cAMP signaling.JNeurosci,2011,31(1):172-183.

[25]Lerner,Epstein.Cyclic nucleotide phosphodiesterases as targets for treatment of haematologicalmalignancies.Biochem.J,2006,393:21-41.

[26]Zhang LF,Jin CH,Lu XB,et al.Aluminium chloride impairs long-term memory and downregulates cAMPPKA-CREB signalling in rats.Toxicology,2014,323:95-108.

[27]Shi JP,Chen WD,Zhou JQ,et al.Investigation of single nucleotide polymorphisms in phosphodiesterase 4D gene in Mongol and Han patients with ischemic stroke in Inner Mongolia.Genet Mol Res,2015,14(3):10281-10287.

[28]Zhang YH,Guo XH,Zhang QM,et al.Serum CRP and urinary trypsin inhibitor implicate postoperative cognitive dysfunction especially in elderly patients.Int JNeurosci,2015,125(7):501-506.

[29]Yazm􀆐n,Carlos Alfonso,Isela,et al.The role of gene variants of the inflammatory markers CRP and TNF-αin cardiovascular heart disease:systematic review and meta-analysis.Int J Clin Exp Med,2015,8(8):11958-11984.

[30]Najar,Ghaderian,Panah,et al.C-reactive protein(CRP)gene polymorphisms :implication in CRP plasma levels and susceptibility to acutemyocardial infarction.Mol Biol Rep,2012,39:3705-3712.

[31]Mathew,Podgoreanu,Grocott et al,Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery.JAm Coll Cardiol,2007,49(19):1934-1942.